Capricor Therapeutics, Inc. (CAPR) vs Puma Biotechnology, Inc. (PBYI)

Capricor Therapeutics, Inc. and Puma Biotechnology, Inc. are both Biotechnology companies. Capricor Therapeutics, Inc. and Puma Biotechnology, Inc. are of similar size ($508.7M and $506.9M). Capricor Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.1×. Puma Biotechnology, Inc. grew revenue faster over the last twelve months: −2.86% against −11.6%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs −1,019.7%). Across the 18 metrics below, Puma Biotechnology, Inc. leads on 12 and Capricor Therapeutics, Inc. on 6.